Skip to main content
NEUROPHET Inc. logo

NEUROPHET Inc. — Investor Relations & Filings

Ticker · 380550 ISIN · KR7380550004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 41 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 380550

About NEUROPHET Inc.

http://www.neurophet.com/en

NEUROPHET Inc. is a medical artificial intelligence company that develops solutions for brain disorders. The company specializes in AI-driven brain imaging analysis software designed to support the entire lifecycle of brain disease management, from diagnosis and treatment planning to drug efficacy monitoring and clinical research. Its core technologies are applied across various neurological fields, including neurodegenerative diseases like Alzheimer's, neurovascular conditions, and neuromodulation therapies. By leveraging advanced neuroscience and AI, Neurophet aims to provide accurate and consistent analytical results to medical professionals and researchers to aid in the treatment of brain diseases.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is clearly titled “분기보고서” (Quarterly Report) covering the period 2026-01-01 to 2026-03-31 (the 10th fiscal period). It contains detailed business descriptions, segment sales tables, raw material purchases, key customer revenue breakdowns, long-term supply contract details, foreign exchange risk disclosures, and other substantive financial and operational information typical of an interim or quarterly report. This matches the Interim/Quarterly Report definition (Code: IR). Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-04-30 Korean
증권발행결과(자율공시) (제3자배정-전환우선주)
Share Issue/Capital Change Classification · 90% confidence The document is an official announcement of the results of a securities issuance (third-party allotment of convertible preferred shares), including details on share count, issuance amount, resolution and payment dates. This clearly falls under announcements of new share issues or capital changes.
2026-04-20 Korean
증권발행결과(자율공시) (제2회차 CB)
Capital/Financing Update Classification · 90% confidence The document is a voluntary disclosure of the results of a securities issuance (a convertible bond), detailing issuance amount, dates, and terms. This is a financing activity announcement rather than a full report or equity dividend, so it fits the Capital/Financing Update category.
2026-04-20 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 92% confidence The document is a Korean "주요사항보고서(유상증자결정)" – a significant matters report announcing a decision on a paid-in capital increase via third-party allocation of new shares. It details the issuance of new ordinary and preferred stock, conversion terms, pricing calculations, and related terms, which clearly constitutes a Share Issue/Capital Change announcement. Therefore, it falls under the "Share Issue/Capital Change" category.
2026-04-10 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 88% confidence The document is a Korean "주요사항보고서" (Major Event Report) filed with the Financial Services Commission and Korea Exchange describing the decision to issue convertible bonds. It provides detailed terms of the bond issuance, conversion mechanics, put and call options, and lists investors – clearly an update on the company’s financing activity. This matches the definition for Capital/Financing Update (CAP).
2026-04-10 Korean

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.